Oncology Institute, Radiation Therapy Unit, Rambam Medical Center, Haifa, Israel; Breast Radiation Unit, Sheba Tel Ha'shomer, Ramat Gan, Israel; School for Oncology and Developmental Biology (GROW), Maastricht University Medical Centre, Maastricht, the Netherlands.
Department of Oncology, Vejle Hospital, Vejle, Denmark.
Clin Oncol (R Coll Radiol). 2021 Jan;33(1):20-29. doi: 10.1016/j.clon.2020.09.004. Epub 2020 Sep 26.
To evaluate how common radiation therapy techniques perform in the setting of the new European Society for Radiotherapy and Oncology-Advisory Committee in Radiation Oncology Practice (ESTRO-ACROP) delineation recommendations for immediate breast reconstruction (IBR).
Seven Danish radiation therapy centres and six international European centres participated in this project. Two breast cancer cases (one left-sided and one right-sided) with a retropectoral implant were chosen for radiation therapy planning using deep-inspiration breath-hold. Target volumes were delineated according to ESTRO-ACROP delineation recommendations. The centres were asked to plan the cases using any radiation therapy technique according to the Danish Breast Cancer Group plan objectives.
In total, 35 treatment plans were collected. Half of the submitted plans, for both the left-sided and the right-sided case, used the field-in-field (FiF) technique (nine for each), a quarter used volumetric arc radiation therapy (VMAT; five for right-sided, four for left-sided) and the remaining quarter was a mix of inverse intensity-modulated radiation therapy (IMRT), helicoidal therapy and hybrid (combined open fields and VMAT) techniques. Mean clinical target volume doses were in the range 99-102% of the prescribed dose. The median FiF mean heart dose (MHD) for right-sided radiation therapy was 1 Gy (range 0.8-3.7) and 5.2 Gy for left-sided radiation therapy (range 2.2-6.5). For right-sided radiation therapy, the median VMAT MHD was 3.42 Gy, for IMRT was 2.3 Gy and for helicoidal therapy was 5.1 Gy. For left-sided radiation therapy, the median VMAT MHD was 6.3 Gy, for IMRT was 7.8 Gy and for helicoidal therapy was 7.3 Gy.
Different radiation therapy techniques could be used to plan radiation therapy in the setting of IBR. FiF provided good coverage with acceptable organ at risk doses. The best dose distribution results as a trade-off between the objectives of target volume coverage and high-dose organ at risk inclusion. The radiation therapy technique affects the interplay between these objectives.
评估在新的欧洲放射肿瘤学会-放射肿瘤实践咨询委员会(ESTRO-ACROP)即刻乳房重建(IBR)勾画建议的背景下,常见放射治疗技术的应用效果。
7 个丹麦放射治疗中心和 6 个国际欧洲中心参与了本项目。选择了 2 例接受背阔肌下植入物的左侧和右侧乳腺癌病例,使用深吸气屏气进行放射治疗计划。根据 ESTRO-ACROP 勾画建议勾画靶区。要求各中心根据丹麦乳腺癌小组的计划目标,使用任何放射治疗技术为病例制定计划。
共收集了 35 份治疗计划。提交的计划中,有一半(左侧和右侧病例各 9 例)使用了场中场(FiF)技术,四分之一使用了容积弧形调强放疗(VMAT;右侧 5 例,左侧 4 例),其余四分之一是逆向调强放疗(IMRT)、螺旋放疗和混合(开放野和 VMAT 联合)技术的混合。临床靶区剂量的平均值在处方剂量的 99-102%之间。右侧放射治疗 FiF 平均心脏剂量(MHD)中位数为 1 Gy(范围 0.8-3.7),左侧为 5.2 Gy(范围 2.2-6.5)。对于右侧放射治疗,VMAT MHD 的中位数为 3.42 Gy,IMRT 为 2.3 Gy,螺旋放疗为 5.1 Gy。对于左侧放射治疗,VMAT MHD 的中位数为 6.3 Gy,IMRT 为 7.8 Gy,螺旋放疗为 7.3 Gy。
不同的放射治疗技术可用于 IBR 放射治疗计划。FiF 提供了良好的覆盖,同时具有可接受的危及器官剂量。最好的剂量分布结果是在靶区覆盖和高危器官高剂量纳入这两个目标之间的权衡。放射治疗技术会影响这些目标之间的相互作用。